Boston Scientific Estimates Q2 2024 Net Sales Growth Of Approximately 10.5%-12.5% Y/Y On Reported Basis, And Approximately 10%-12% On Organic Basis
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific projects its Q2 2024 net sales to grow by about 10.5%-12.5% year-over-year on a reported basis, and around 10%-12% on an organic basis.
April 24, 2024 | 10:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific expects its Q2 2024 net sales to increase by approximately 10.5%-12.5% year-over-year on a reported basis, and about 10%-12% on an organic basis.
The projected sales growth for Boston Scientific in Q2 2024 is a positive indicator of the company's performance and potential for revenue increase. This forecast is likely to be viewed favorably by investors, potentially leading to a positive impact on the stock price in the short term. The distinction between reported and organic growth rates highlights the company's operational efficiency and market expansion efforts.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100